GTP depletion synergizes the anti-proliferative activity of chemotherapeutic agents in a cell type-dependent manner

Biochemical and Biophysical Research Communications

Volumn 414, Issue 2, 2011, Pages 403-408

  Lin, Tao ^a   Meng, Lingjun ^a   Tsai, Robert Y L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Mycophenolic acid; Nucleostemin; Ribosomal RNA; Synergy

Indexed keywords

ANTIMITOTIC AGENT; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GUANOSINE TRIPHOSPHATE; IRINOTECAN; MYCOPHENOLIC ACID; OXALIPLATIN; PACLITAXEL; RNA POLYMERASE;

ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; DRUG ACTIVITY; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; FLUOROURACIL; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HUMANS; MICE; MYCOPHENOLIC ACID; NUCLEAR PROTEINS; PACLITAXEL; RIBOSOMES;

EID: 80054839266     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.091     Document Type: Article

References (18)

1. Birch A.J., Wright J.J. A total synthesis of mycophenolic acid. Aust. J. Chem. 1969, 22:2635-2644.
2. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000, 47:85-118.
3. Sweeney M.J. Mycophenolic acid and its mechanism of action in cancer and psoriasis. Jpn. J. Antibiot. 1977, 30(Suppl.):85-92.
4. Sun X.X., Dai M.S., Lu H. Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J. Biol. Chem. 2008, 283:12387-12392.
5. Heinschink A., Raab M., Daxecker H., Griesmacher A., Muller M.M. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. Clin. Chim. Acta 2000, 300:23-28.
6. Laliberte J., Yee A., Xiong Y., Mitchell B.S. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood 1998, 91:2896-2904.
7. Gu J.J., Gathy K., Santiago L., Chen E., Huang M., Graves L.M., Mitchell B.S. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Blood 2003, 101:4958-4965.
8. Takebe N., Cheng X., Fandy T.E., Srivastava R.K., Wu S., Shankar S., Bauer K., Shaughnessy J., Tricot G. IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol. Cancer Ther. 2006, 5:457-466.
9. Ishitsuka K., Hideshima T., Hamasaki M., Raje N., Kumar S., Podar K., Le Gouill S., Shiraishi N., Yasui H., Roccaro A.M., Tai Y.Z., Chauhan D., Fram R., Tamura K., Jain J., Anderson K.C. Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene 2005, 24:5888-5896.
10. Huang M., Itahana K., Zhang Y., Mitchell B.S. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res. 2009, 69:3004-3012.
11. Tsai R.Y., McKay R.D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 2002, 16:2991-3003.
12. Gu J.J., Santiago L., Mitchell B.S. Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl. Blood 2005, 105:3270-3277.
13. Lin T., Meng L., Li Y., Tsai R.Y. Tumor-initiating function of nucleostemin-enriched mammary tumor cells. Cancer Res. 2010, 70:9444-9452.
14. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
15. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., Goulet R., Badve S., Nakshatri H. CD44+/breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006, 8:R59.
16. Hui L., Zheng Y., Yan Y., Bargonetti J., Foster D.A. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 2006, 25:7305-7310.
17. Romanova L., Grand A., Zhang L., Rayner S., Katoku-Kikyo N., Kellner S., Kikyo N. Critical role of nucleostemin in pre-rRNA processing. J. Biol. Chem. 2009, 284:4968-4977.
18. Rosby R., Cui Z., Rogers E., Delivron M.A., Robinson V.L., Dimario P.J. Knockdown of the Drosophila GTPase, nucleostemin 1, impairs large ribosomal subunit biogenesis, cell growth, and midgut precursor cell maintenance. Mol. Biol. Cell 2009, 20:4424-4434.